Prenetics Global Limited
PREConsumer DefensiveNASDAQPackaged Foods
Scan Results
Daily timeframeHeadquartered within the consumer defensive sector, Prenetics Global Limited focuses on Packaged Foods services and products. Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company carries a $310.9M market cap, placing it firmly in the small-cap category. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.
Market Cap
$310.9M
Beta
0.25
P/E (TTM)
—
P/E (Fwd)
-19.25
EPS (TTM)
$-3.51
EPS (Fwd)
$-0.95
ROE
-40.8%
ROA
-13.5%
Cash
$115.4M
Total Debt
$457,000
Free CF
-$84.7M
52W Change
131.2%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $115.4M in cash comfortably exceeding the $457K debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company is burning cash, with free cash flow at -$84.7M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -40.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $13.2M (2022) to $92.4M (2025), reflecting a 602% increase over the period.
With a beta below 0.7, Prenetics Global Limited typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. With cash comfortably exceeding debt, PRE has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing PRE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.